Skip Navigation LinksHome > June 2010 - Volume 53 - Issue 2 > Amniotic Fluid Embolism
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e3181e0ead2
Respiratory Disease in Pregnancy

Amniotic Fluid Embolism


Collapse Box


Amniotic fluid embolism (AFE) remains an enigmatic, but devastating obstetrical condition associated with significant maternal and newborn morbidity and mortality. Although our understanding of this condition is incomplete, research over the past 2 decades has altered traditional concepts of both the causation and pathophysiology of AFE. Although maternal treatment remains primarily supportive, prompt delivery of the fetus can substantially improve neonatal outcome after AFE-induced cardiac arrest. Newer biochemical markers may in the future enhance the specificity and sensitivity of this clinical diagnosis and could potentially lead to improved therapy.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.